Massimo Massaia

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

Francesco Passamonti, Chiara Cattaneo, Luca Arcaini et al. · The Lancet Haematology · 2020 · 551 citations · Full text

A Comparison of Allografting with Autografting for Newly Diagnosed Myeloma

Benedetto Bruno, Marcello Rotta, Francesca Patriarca et al. · New England Journal of Medicine · 2007 · 504 citations

Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25− into CD25+ T regulatory cells

Antonio Curti, Simona Pandolfi, Barbara Valzasina et al. · Blood · 2006 · 385 citations · Full text

Zoledronic acid repolarizes tumour‐associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway

Marta Coscia, Elena Quaglino, Manuela Iezzi et al. · Journal of Cellular and Molecular Medicine · 2009 · 263 citations · Full text

Chemoprevention Strategy, Immunology, Cancer Biology +21

CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib

Roberto Piva, Bruce Ruggeri, Michael Williams et al. · Blood · 2007 · 252 citations · Full text